North America Antibody Discovery Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Antibody Discovery Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Antibody Discovery Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1
5.1.2 Rising prevalence of chronic diseases
5.1.3 Increasing demand for personalized medicine
5.1.4 Technological advancements in antibody discovery platforms
5.1.5 Growing biopharmaceutical industry
5.1.6 Increasing R&D expenditure in pharmaceuticals
5.1.7 Rising demand for safer and more effective therapies
5.1.8 Increasing collaborations between academia and industry
5.1.9 Growing focus on patient-centered drug development

5.2 Market Opportunities

5.2.1
5.2.2 Rising demand for biologics
5.2.3 Increasing focus on personalized medicine
5.2.4 Technological advancements in antibody engineering
5.2.5 Growing prevalence of chronic diseases
5.2.6 Increasing R&D investments in biopharmaceuticals
5.2.7 Emerging markets with high unmet medical needs
5.2.8 Expanding pipeline of antibody-based therapeutics
5.2.9 Increasing collaborations between pharma and biotech companies
5.2.10 Growing interest in antibody-drug conjugates (ADCs)
5.2.11 Rising demand for safer and more effective therapies

5.3 Future Trends

5.3.1
5.3.2 Increasing focus on antibody-drug conjugates (ADCs)
5.3.3 Advancements in bispecific antibodies
5.3.4 Rising interest in nanobodies
5.3.5 Growing demand for personalized medicine
5.3.6 Increasing use of AI and machine learning in antibody discovery
5.3.7 Emerging technologies like phage display and yeast display
5.3.8 Increasing collaborations between academia and industry
5.3.9 Focus on developing antibody therapies for rare diseases
5.3.10 Rising demand for biosimilars and biobetters

5.4 Impact of Drivers and Restraints

6. North America Antibody Discovery Market Regional Analysis

6.1 North America Antibody Discovery Market Overview

6.2 North America Antibody Discovery Market Revenue 2020-2030 (US$ Million)

6.3 North America Antibody Discovery Market Forecast Analysis

7. North America Antibody Discovery Market Analysis – by Antibody Type

7.1 Monoclonal Antibodies

7.1.1 Overview
7.1.2 Monoclonal Antibodies: North America Antibody Discovery Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Polyclonal Antibodies

7.2.1 Overview
7.2.2 Polyclonal Antibodies: North America Antibody Discovery Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Antibody Discovery Market Analysis – by Nature

8.1 Human and Humanized

8.1.1 Overview
8.1.2 Human and Humanized: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Chimeric

8.2.1 Overview
8.2.2 Chimeric: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Murine

8.3.1 Overview
8.3.2 Murine: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Antibody Discovery Market Analysis – by End User

9.1 Pharmaceutical and Biotechnology Companies

9.1.1 Overview
9.1.2 Murine: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Research Laboratories

9.2.1 Overview
9.2.2 Murine: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

10. North America Antibody Discovery Market – North America Analysis

10.1 North America

10.1.1 North America Antibody Discovery Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 North America Antibody Discovery Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 US: North America Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.1.2 US: North America Antibody Discovery Market Breakdown, by Nature
10.1.1.1.3 US: North America Antibody Discovery Market Breakdown, by End User

10.1.1.2 Canada: North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Canada: North America Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.2.2 Canada: North America Antibody Discovery Market Breakdown, by Nature
10.1.1.2.3 Canada: North America Antibody Discovery Market Breakdown, by End User

10.1.1.3 Mexico : North America Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Mexico : North America Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.3.2 Mexico : North America Antibody Discovery Market Breakdown, by Nature
10.1.1.3.3 Mexico : North America Antibody Discovery Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Antibody Discovery Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Charles River Laboratories International Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Creative Biolabs Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Evotec SE

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Bruker Cellular Analysis Inc

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 BioDuro LLC

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Sartorius AG

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Aragen Life Sciences Ltd

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Twist Bioscience Corp

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 NanoCellect Biomedical Inc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

13.10 Biocytogen Pharmaceuticals Beijing Co Ltd

13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights